Activated Met signalling in the developing mouse heart leads to cardiac disease.
<h4>Background</h4>The Hepatocyte Growth Factor (HGF) is a pleiotropic cytokine involved in many physiological processes, including skeletal muscle, placenta and liver development. Little is known about its role and that of Met tyrosine kinase receptor in cardiac development.<h4>Me...
Guardado en:
Autores principales: | Christian Leo, Valentina Sala, Mara Morello, Amedeo Chiribiri, Ilan Riess, Daniele Mancardi, Stefano Schiaffino, Carola Ponzetto, Tiziana Crepaldi |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ff6f1a6b6c37420facb91224cc26c823 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
c-Met activation leads to the establishment of a TGFβ-receptor regulatory network in bladder cancer progression
por: Wen Jing Sim, et al.
Publicado: (2019) -
MET amplification identified by next-generation sequencing and its clinical relevance for MET inhibitors
por: Lun-Xi Peng, et al.
Publicado: (2021) -
Heart Transplant and Ventricular Assist: Cardiac Surgery and Heart Failure Perspective
por: Michael T Cain, et al.
Publicado: (2021) -
Author Correction: c-Met activation leads to the establishment of a TGFβ-receptor regulatory network in bladder cancer progression
por: Wen Jing Sim, et al.
Publicado: (2019) -
Targeting MET in cancer therapy
por: Hong-Nan Mo, et al.
Publicado: (2017)